搜索
Milestones
问
2022.04 — PM1021: IND filing for phase I study in Australia
答
PM1021: IND filing for phase I study in Australia
问
2022.03 — PM1032 & PM1015: IND approval for FIH Phase I studies
答
PM1032 & PM1015: IND approval for FIH Phase I studies
问
2022.02 — PM8002: entered clinical phase II studies
答
PM8002: entered clinical phase II studies
问
2022.01 — PM1022: IND approval for FIH phase I study
答
PM1022: IND approval for FIH phase I study
Copyright © 2022 Biotheus Inc. All Rights Reserved 粤ICP备2021122492号